Quality of biological active substances produced by transgene expression in animals

Current effective version PDF iconAdopted guideline
Reference number CHMP/BWP/151897/2013
Published 10/06/2013
Effective from 01/12/2013
Keywords Transgenic animals, recombinant protein, matrix
Description This document addresses the use of transgenic animals as a manufacturing technology for the production of recombinant therapeutic proteins. Guidance is provided on the approaches that should be employed in order to achieve satisfactory quality for biological active substances to be produced using this technology.


Document history

First version

Current version

PDF iconAdopted guideline

 

PDF iconOverview of comments

 

PDF iconDraft guideline

 

PDF iconConcept paper

In operation: 01/12/2013–present

 

Published: 10/06/2013

 

Published: 31/05/2012

 

Published: 20/05/2009

Superseded document PDF iconAdopted guideline Dates in operation: 31/06/1995–01/12/2013


Related content


How useful was this page?

Add your rating